SAO:BRAP4

Bradespar S.A. · SAO · Financial Services · BRL · FY for 2025

Figures on this page computed 2026-11-08 12:56 UTC

Last close

n/aBRL

Market data

  • 13.8xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    BRL
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    This measure is not defined for this kind of company, so there is no peer group it belongs in.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    BRL
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 84.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    BRL
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 103.6%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    BRL
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    This figure is scaled by the business model rather than by management, so it can only be read against its own sector. We do not hold a large enough sector cohort, and we will not fall back to the whole market.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    BRL
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 12.5%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    BRL
    • computed

Then and now

lens 3 of 9
Five filed facts, 2014 against 2025.
Fact20142025Change
Sales122,110,000646,879,000+430%
Profit101,483,000546,993,000+439%
Free cash flow597,955,000670,015,000+12.0%
Debt1,165,109,0004,330,000-99.6%
Shares in issue394,814,000393,096,610-0.4%

The same five facts for 2014 and 2025, each read from the year's own filing.

The same five facts for 2014 and 2025, each read from the year's own filing.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2014

  • Sales, 2014122,110,000
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    BRL
  • Sales, 2025646,879,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    BRL
  • Profit, 2014101,483,000
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    BRL
  • Profit, 2025546,993,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    BRL
  • Free cash flow, 2014597,955,000
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    BRL
  • Free cash flow, 2025670,015,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    BRL
  • Debt, 20141,165,109,000
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    BRL
  • Debt, 20254,330,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    BRL
  • Shares in issue, 2014394,814,000
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    BRL
  • Shares in issue, 2025393,096,610Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    BRL

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.